Immunovant, Inc. IMVT
33.17 USD -0.04 (-0.12%)
Regular-session close
33.51 +0.34 +1.03%
Pre-market · Nov 19, 5:40 AM ET
32.59 Day range 34.23
21.86 52-week range 45.42
- YTD
- +30.49%
- 1 year
- +40.02%
News
benzinga.com David Einhorn Bets on Aluminum in Q3: Here Are His New Stock Picks, Fund Changes DME Capital Management reveals its new third-quarter stock picks. Here's what David Einhorn has been buying.benzinga.com Truist Securities Maintains Hold on Immunovant, Raises Price Target to $33 Truist Securities analyst Danielle Brill maintains Immunovant (NASDAQ:IMVT) with a Hold and raises the price target from $30 to $33.
benzinga.com Wells Fargo Maintains Overweight on Immunovant, Raises Price Target to $47 Wells Fargo analyst Derek Archila maintains Immunovant (NASDAQ:IMVT) with a Overweight and raises the price target from $45 to $47.
benzinga.com Immunovant Meets Primary Endpoint In Difficult-To-Treat Rheumatoid Arthritis Study Immunovant reports positive trial results for IMVT-1402 in rheumatoid arthritis and plans FDA discussions on a registrational pathway.
benzinga.com KKR, Constellation Energy On Deck Monday As Private Credit, Power Face Test KKR headlines Monday’s reports, with investors weighing whether fundraising momentum can offset a sharp year-to-date stock decline. Constellation Energy, Barrick Mining, Ferguson Enterprises and ORIX…
